Intrinsic Value of S&P & Nasdaq Contact Us

Onconova Therapeutics, Inc. ONTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ONTX

Onconova Therapeutics, Inc. (ONTX) has a market capitalization of $20.9M and trades at $1.00. The 52-week range is 0.5509-1.45.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-10,724,800.00, annual revenue of $226B.

The stock has a beta of 1.35, operates in the Healthcare sector.

Trading Data
Current Price$1.00
52-Week Range0.5509-1.45
Volume1.25M
Avg Volume (30D)126.34K
Market Cap$20.9M
Beta (1Y)1.35
Company
IPO Date2013-07-25
Employees16
CEOSteven M. Fruchtman
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS68232V8019
CUSIP68232V801
Income (Latest Year)
Revenue$226B
Gross Profit$-117.24T
EBITDA$-142.37T
Operating Income$-142.37T
Net Income$-166.52T
EPS$-10,724,800.00
EPS Diluted$-10,724,800.00
Shares Outstanding$15.53M
Balance Sheet (Latest Year)
Total Assets$24.96T
Current Assets$24.95T
Cash & ST Investments$21.34T
Total Liabilities$56.59T
Net Debt$-21.34T
Valuation Ratios
P/E Ratio-0
P/S Ratio0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message